Takeda launches pharmaceutical company with PE partner & more: 4 GI company key notes

Here are four updates on gastroenterology companies from the past week:

Takeda and Frazier Healthcare Partners launched Phathom Pharmaceuticals to develop gastrointestinal treatments.

The FDA accepted Takeda's application for an injectable version of its ulcerative colitis drug Entyvio.

Virgo Surgical Video Solutions celebrated two milestones when it received a patent and surpassed 30,000 recordings with its automated video-recording platform.

Motus GI released its first quarter 2019 financial results, posting a $6.3 million net loss, or a $0.29 loss per diluted share. Read more.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast